Oncotelic Therapeutics, Inc. — Balance Sheet Charts
49 snapshots of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-16.9% -$6M
$30M
Current Assets↓-10.4% -$31K
$272K
Cash & Equivalents↓-29.4% -$71K
$170K
ST Investments↓-81.7% -$10M
$2M
Receivables↓-3.9% -$772
$19K
Net PPE
$19K
Goodwill↓-50.4% -$6M
$6M
Intangibles↓-6.0% -$51K
$809K
Total Liabilities↑+8.7% +$1M
$18M
Current Liabilities↓-2.5% -$418K
$17M
Account Payables↓-82.4% -$2M
$343K
Short-Term Debt↑+352.5% +$1M
$2M
Stockholders Equity↓-39.5% -$8M
$12M
Retained Earnings↓-29.3% -$8M
$-34M
Operating Lease ROU Asset
$51K
Operating Lease Liability
$55K
Gross PP&E↑+0.0% +$0
$268K
Accumulated Depreciation↑+10.0% +$10K
$112K
Total Debt Carrying Amount
$1M